Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia

NCT03602053 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Diarrhea
Diarrhea Rotavirus

Interventions

BIOLOGICAL: ROTAVAC®
BIOLOGICAL: ROTAVAC 5D
BIOLOGICAL: Rotarix®

Sponsor

Centre for Infectious Disease Research in Zambia

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]